Pomegranate Extract
Punica granatum fruit products studied for cardiovascular, cognitive, and cancer-related outcomes. Human findings are limited and preparation-specific; some biomarker changes have not translated into established clinical benefits.
Pharmacokinetic model
A route-level PK model for pomegranate extract is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Supplement
- Suggested cadence
- once daily
Research behind this entry
-
Impact of Pomegranate Extract Supplementation on Physical and Cognitive Function in Community-Dwelling Older Adults Aged 55-70 Years: A Randomised Double-Blind Clinical Trial
Eighty-six adults received 740 mg/day extract or placebo for 12 weeks. One reasoning outcome improved, several outcomes only trended, and physical function did not differ. PMID 39997528 is the verified record.
-
A review of pomegranate in prostate cancer
Review of laboratory and early clinical prostate-cancer research. It describes exploratory biomarker findings but does not establish pomegranate extract as a cancer treatment.
2 published studies referenced in the app, each with a plain-language summary.